ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7689
-0.08%
Brent Oil
82.345
-0.05%
Bitcoin
61,055.16
-0.64%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Aptose Biosciences Inc (APTO)

  7. Aptose Biosciences Inc (APTO) Noticias

APTO

Aptose Biosciences (APTO)

Aptose Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:APTO
FechaHoraFuenteTítuloSímboloCompañía
10/05/202410:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
06/05/202415:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
14/02/202415:51Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APTOAptose Biosciences Inc
26/01/202416:30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:APTOAptose Biosciences Inc
25/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APTOAptose Biosciences Inc
25/01/202420:44Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:APTOAptose Biosciences Inc
19/01/202420:50Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APTOAptose Biosciences Inc
09/11/202316:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APTOAptose Biosciences Inc
21/09/202316:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APTOAptose Biosciences Inc
06/07/202315:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:APTOAptose Biosciences Inc
26/06/202315:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTOAptose Biosciences Inc
20/06/202305:01Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:APTOAptose Biosciences Inc
19/04/202305:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:APTOAptose Biosciences Inc
03/04/202315:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APTOAptose Biosciences Inc
24/03/202305:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APTOAptose Biosciences Inc
14/02/202316:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APTOAptose Biosciences Inc
17/01/202305:08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APTOAptose Biosciences Inc
12/12/202210:55TipRanksJonesTrading Keeps Their Buy Rating on Aptose Biosciences (APTO)NASDAQ:APTOAptose Biosciences Inc
17/11/202208:55TipRanksAptose Biosciences (APTO) Gets a Buy from H.C. WainwrightNASDAQ:APTOAptose Biosciences Inc
02/11/202206:45TipRanksJonesTrading Remains a Buy on Aptose Biosciences (APTO)NASDAQ:APTOAptose Biosciences Inc
02/11/202205:15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Aptose Biosciences (APTO)NASDAQ:APTOAptose Biosciences Inc
01/11/202215:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APTOAptose Biosciences Inc
24/10/202205:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APTOAptose Biosciences Inc
21/10/202216:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:APTOAptose Biosciences Inc
11/10/202205:01Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:APTOAptose Biosciences Inc
21/09/202217:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTOAptose Biosciences Inc
03/08/202207:22TipRanksJonesTrading Thinks Aptose Biosciences’ Stock is Going to RecoverNASDAQ:APTOAptose Biosciences Inc
03/08/202206:21TipRanksCanaccord Genuity Thinks Aptose Biosciences’ Stock is Going to RecoverNASDAQ:APTOAptose Biosciences Inc
03/08/202205:26TipRanksH.C. Wainwright Thinks Aptose Biosciences’ Stock is Going to RecoverNASDAQ:APTOAptose Biosciences Inc
28/06/202215:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:APTOAptose Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:APTO

Su Consulta Reciente

CCOM
US30
US 30
NASDAQ
MSFT
Microsoft
NASDAQ
NVDA
NVIDIA
COIN
BTCUSD
Bitcoin
NYSE
XOM
Exxon Mobil
FX
EURUSD
Euro vs US Dollar
COIN
ETHUSD
Ethereum
CCOM
US500
US 500
AMEX
XLV
Health Care Select Sector
NASDAQ
AMZN
Amazon.com
PM
XAUUSD
Gold vs US Dollar
NASDAQ
TSLA
Tesla
AMEX
XLF
Financial Select Sector
FX
USDMXN
US Dollar vs MXN
NYSE
MCD
McDonalds
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados